ÂÜÀòÂÒÂ×

Hunter Louderback, JD, MA, MS has an extensive work experience spanning from 2014 to the present. Hunter currently holds the position of Senior Compliance Specialist at SPR Therapeutics, Inc. starting in April 2023. Prior to this, they worked as a Compliance Intern at SPR Therapeutics, Inc. from June 2022 to December 2022. Before joining SPR Therapeutics, Inc., Hunter was an Extern at Parker Hannifin from January 2022 to April 2022. Hunter also served as a Summer Associate at Nixon Gwilt Law in May 2021 to July 2021 and as an Extern at the Ohio Patent Pro Bono Program from January 2021 to April 2021. In 2020, they gained experience as a Summer Extern at Alphamicron, Inc. From 2014 to 2020, Hunter held multiple roles at Technium, including Chief Science Officer from May 2018 to March 2020, Business Development and Licensing Engineer from May 2016 to May 2018, and Technical Intern from March 2014 to May 2016. Hunter also worked as a Business Development and Project Manager at Aether Therapeutics from December 2016 to March 2020. Additionally, they held the position of Business Development Associate at Mu Therapeutics from March 2015 to March 2020 and Business Development and Licensing Engineer at TAO Life Sciences from November 2014 to March 2020.

Hunter Louderback has an extensive education history. In 2005, they completed their high school education at Saint Charles Preparatory School. Hunter then went on to attend Kenyon College from 2009 to 2011, where they focused on Biochemistry and Legal Studies. After that, from 2011 to 2013, Hunter pursued a Bachelor of Science degree in Biochemistry with a minor in Economics at The Ohio State University. In 2014, they furthered their education at Case Western Reserve University, where they completed a Master of Science degree in Biology with a specialization in Entrepreneurial Biotechnology. Hunter continued their studies at Case Western Reserve University School of Law, earning their Juris Doctor degree in 2019, while also specializing in Food and Drug Law and Intellectual Property. Later, from 2022 to 2023, they achieved a Master of Arts degree in Compliance and Risk Management, with a specialization in Food and Drug Law and Intellectual Property from Case Western Reserve University School of Law.